NRSN$1.37-4.20%
NeuroSense Therapeutics Ltd.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: ILExchange: Nasdaq
Mkt Cap:$2.6M
Float & O/S:
Inst Own:
DilutionScan read 35 of NeuroSense Therapeutics Ltd.'s SEC filings and found 7 warrant series, 2 ATM programs, 1 equity line, 5 shelf registrations, 1 S-1 registration and 2 completed offerings on file for NRSN. The latest dilution event on file is ATM sales on Jul 31, 2026. Analysis updated Oct 1, 2026.
